CrushSCI.com
107.3Average days
104.5Median days
9Fastest days
195Longest days
4192025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

90 days

Assessing the Risk of Neonatal Opioid Toxicity from Breastfeeding: Challenge to the Pediatric Clinical Pharmacology Modeling and Simulation Community

Authors
J. Steven Leeder; Saskia N. de Wildt; Andrea Gaedigk; Michael D. Reed; Catherijne A.J. KnibbeShow moreShow less
Affiliations
1. Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics Children's Mercy Kansas City Missouri USA; 2. Children's Mercy Research Institute Kansas City Missouri USA; 3. School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA; 4. Department of Pharmacy, Pharmacology and Toxicology Radboud University Medical Center Netherlands; 5. Department of Neonatal and Pediatric Intensive Care Erasmus MC‐Sophia Children's Hospital Rotterdam Netherlands; 6. School of Medicine Case Western Reserve University Cleveland Ohio USA; 7. Department of Clinical Pharmacy St. Antonius Hospital Nieuwegein & Utrecht Netherlands; 8. Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre of Drug Research Leiden University Leiden NetherlandsShow moreShow less
Source PDF DOI Publisher page
178 days

Model‐Informed Evaluation of Drug–Drug Interaction Recommendations for Amlodipine and Nirmatrelvir‐Ritonavir: A Hypothesis‐Generating Analysis

Authors
Tat Ming Ng; Bernice Xin Ting Chan; Jiafang Chen; Angelyn Shu Min Tan; Ziteng Wang; Arjun Kolappurath Madathil; Annabel Xing Rong Chua; Barnaby Young; Eric Chun Yong ChanShow moreShow less
Affiliations
1. Division of Pharmacy Tan Tock Seng Hospital, NHG Health Singapore; 2. Department of Pharmacy and Pharmaceutical Science, Faculty of Science National University of Singapore Singapore; 3. National Centre for Infectious Diseases, NHG Health Singapore; 4. Lee Kong Chian School of Medicine, Nanyang Technological University SingaporeShow moreShow less
Source PDF DOI Publisher page
95 days

Drug Repurposing in Pre‐Eclampsia: Maternal Pharmacokinetic and Pharmacodynamic Considerations for Clinical Trial Design

Authors
Cassius M. Phogole; Engi Abdel‐Hady Algharably; Eric H. Decloedt; Catherine Anne Cluver; Veshni Pillay‐Fuentes LorenteShow moreShow less
Affiliations
1. Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences Stellenbosch University Cape Town South Africa; 2. Institute for Clinical Pharmacology and Toxicology Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin Germany; 3. SAMRC Preeclampsia Extramural Research Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences Stellenbosch University Cape Town South AfricaShow moreShow less
Source PDF DOI Publisher page
102 days

Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review

Authors
Aniket Chawla; Andreas Halman; Sean M. Carter; Claire Moore; Rachel ConyersShow moreShow less
Affiliations
1. Murdoch Children's Research Institute Melbourne Victoria Australia; 2. Royal Children's Hospital Melbourne Victoria Australia; 3. University of Melbourne Melbourne Victoria AustraliaShow moreShow less
Source PDF DOI Publisher page
118 days

Identifying Pediatric and Developmental Screening Targets With Biologically Informed Molecular Representations

Authors
Jose Miguel Acitores Cortina; Martijn C. Schut; Nicholas P. TatonettiShow moreShow less
Affiliations
1. Department of Computational Biomedicine Cedars‐Sinai West Hollywood California USA; 2. Cedars‐Sinai Cancer Cedars‐Sinai Los Angeles California USA; 3. Translational AI for Laboratory Medicine, Department of Laboratory Medicine Amsterdam UMC, Vrije Universiteit Amsterdam The NetherlandsShow moreShow less
Source PDF DOI Publisher page
106 days

Quantitative Sciences in the Model‐Informed Era: From Parallel Functions to a Shared Decision System

Authors
Avery McIntosh; Mohamed Elmeliegy; Jeffrey P. Palmer; Nikolaos Tsamandouras; Vaishali Sahasrabudhe; Blerta ShtyllaShow moreShow less
Affiliations
1. Pfizer, Inc. New York New York USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CLINICAL PHARMACOLOGY & THERAPEUTICS take to review a manuscript?

As of 2026-11-17, CrushSCI has 20 complete review records for CLINICAL PHARMACOLOGY & THERAPEUTICS. The fastest paper went from submission to acceptance in 9 days (The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient, received 2026-04-29, accepted 2026-05-08); the slowest took 195 days. The average is 107.3 days and the median is 104.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.